ReviewNPJ Parkinson's disease2022

Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies.

Pedro Magalhães et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.